BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22167330)

  • 1. Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.
    Hong TT; Zhang RX; Wu XH; Hua D
    Mol Biol Rep; 2012 May; 39(5):5283-9. PubMed ID: 22167330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor gene polymorphisms and gastric cancer risk: a meta-analysis.
    Zhuang M; Peng Z; Wang J; Su X
    J BUON; 2017; 22(3):714-724. PubMed ID: 28730780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP3A4*1B Polymorphism and Cancer Risk: A Meta-Analysis Based on 55 Case-control Studies.
    Zheng Y; Xu Y; Zhou BY; Sun L; Yu PB; Zhang L; Xu J; Wang JJ
    Ann Clin Lab Sci; 2018 Jul; 48(4):538-545. PubMed ID: 30143500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 6. The Protective Effects of the VEGF -2578C>A and -1154G>A Polymorphisms Against Hypertension Susceptibility.
    Kim YR; Hong SH
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):476-80. PubMed ID: 26154735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals.
    Leng WD; He MN; Chen QL; Gong H; Zhang L; Zeng XT
    Mol Biol Rep; 2013 Oct; 40(10):5987-92. PubMed ID: 24057180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis.
    He D; Lu W; Chang K; Liu Y; Zhang J; Zeng Z
    Gene; 2013 Apr; 518(2):296-302. PubMed ID: 23370341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis.
    Xu Y; Zhu S
    Tumour Biol; 2014 Feb; 35(2):1307-11. PubMed ID: 24127038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
    Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
    Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects.
    Cao C; Ying T; Fang JJ; Sun SF; Lv D; Chen ZB; Ma HY; Yu YM; Ding QL; Shu LH; Deng ZC
    Med Oncol; 2011 Dec; 28(4):1169-75. PubMed ID: 20635170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility.
    Qiu LX; Wang K; Yang S; Mao C; Zhao L; Yao L; Zhang J; Zhang QL; Sun S; Xue K
    Mol Biol Rep; 2011 Oct; 38(7):4491-4. PubMed ID: 21127992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
    Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
    Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ATM polymorphisms and cancer risk: a meta-analysis.
    Shen L; Yin ZH; Wan Y; Zhang Y; Li K; Zhou BS
    Mol Biol Rep; 2012 May; 39(5):5719-25. PubMed ID: 22203481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
    Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
    Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.
    Tang W; Qiu H; Jiang H; Wang L; Sun B; Gu H
    PLoS One; 2014; 9(3):e90328. PubMed ID: 24598702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
    Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
    Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between vascular endothelial growth factor (VEGF) +405G>C genetic polymorphism and endometriosis.
    Fang F; Gong L; Wang X; Zhang L
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1177-82. PubMed ID: 25573961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.
    Li K; Li W; Zou H; Zhao L
    Tumour Biol; 2014 Jan; 35(1):351-6. PubMed ID: 23979975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.